Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-004796
Filing Date
2012-05-10
Accepted
2012-05-10 13:12:52
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gfr_10q-033112.htm 10-Q 598529
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15888
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16204
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 4483
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 4500
  Complete submission text file 0001437749-12-004796.txt   2587559

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gfrp-20120331.xml EX-101.INS 394646
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gfrp-20120331.xsd EX-101.SCH 16145
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gfrp-20120331_cal.xml EX-101.CAL 27028
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gfrp-20120331_def.xml EX-101.DEF 86149
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gfrp-20120331_lab.xml EX-101.LAB 112107
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gfrp-20120331_pre.xml EX-101.PRE 89366
Mailing Address 9160 E. DEER TRAIL 9160 E. DEER TRAIL TUCSAN AZ 85710
Business Address SUITE 11405 - 201A STREET MAPLE RIDGE A1 V2X 0Y3 5205771516
GFR PHARMACEUTICALS INC (Filer) CIK: 0001096294 (see all company filings)

EIN.: 770517964 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27959 | Film No.: 12829213
SIC: 2834 Pharmaceutical Preparations